在ST段升高的急性冠状动脉综合征患者中,以加列-3和PIIINP调制准炎症,接受了延迟皮肤冠状动脉干预
Saskia Dyah Handari1,2, Mohammad Saifur Rohman2, Djanggan Sargowo2
1Medical Faculty, Ciputra University, Surabaya 60271, East Java, Indonesia.
科尔奇辛有效地降低了ST升高急性冠状动脉综合征患者的心脏纤维化标志物,这些患者接受了延迟PCI. 这种抗炎药物显示出改善恢复和预防干预后心脏重塑的前景.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 生物标志物研究 生物标志物研究
背景情况:
- 在全球范围内,ST段升高急性冠状动脉综合征 (ST-ACS) 构成了严重的健康负担.
- 心脏重塑和纤维化阻碍了穿皮冠状动脉干预 (PCI) 后的康复.
- 科尔奇辛的抗炎性质可能会调节纤维化标记物,如加勒-3和Procollagen III N-terminal Propeptide (PIIINP).
研究的目的:
- 为了评估胆固醇在调节STE-ACS患者的Galectin-3和PIIINP水平中的有效性.
- 评估科尔奇辛对心脏纤维化生物标志物的影响,在接受早期与延迟PCI的患者中.
主要方法:
- 一个多中心,随机,双盲试验,涉及164名STE-ACS患者.
- 患者在住院后接受了科尔奇辛.
- 在24小时和5天内使用双向ANOVA进行生物标志物分析 (Galectin-3,PIIINP).
主要成果:
- 在早期的PCI中,Galectin-3显著下降,这表明PCI主要的好处超出了胆固醇.
- 在延迟的PCI中,Galectin-3最初增加,但在第五天没有显著下降.
- 在延迟PCI组中,PIIINP水平在第五天显著降低,这表明胆固醇的抗纤维作用.
结论:
- 科尔奇辛在延迟PCI的STE-ACS患者中显示出显著的抗纤维菌疗效.
- 该药物有效地降低了PIIINP,并调节了Galectin-3,这表明它在控制心脏纤维化方面发挥了作用.
- 科尔奇辛可能代表了一种突破性的疗法,用于改善延迟干预患者的治疗结果.
更多相关视频
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
06:43Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
